Today: 20 December 2025
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Rivian Stock (RIVN) Today: Price Targets Raised, Battery Bug Emerges and Big Holders Trim Stakes – November 17, 2025

Rivian Stock (RIVN) Today: Price Targets Raised, Battery Bug Emerges and Big Holders Trim Stakes – November 17, 2025

Rivian Automotive, Inc. (NASDAQ: RIVN) is having another eventful Monday. After a huge post‑earnings rally, the electric‑vehicle maker is now caught between bullish Wall Street upgrades, negative headlines about a battery‑calibration problem, and fresh disclosures showing big investors trimming their
17 November 2025
 ·  ·  ·  ·  · 
Tesla (TSLA) News Today: China Supply Chain Shake-Up, Thiel Trims Stake, AI5 Delay and Divided Wall Street – 17 November 2025

Tesla (TSLA) News Today: China Supply Chain Shake-Up, Thiel Trims Stake, AI5 Delay and Divided Wall Street – 17 November 2025

Tesla (TSLA) stock edges higher on November 17, 2025 as Elon Musk accelerates a shift away from China-made parts, Peter Thiel slashes his stake, AI5 chip timelines slip, and analysts clash over robotaxi upside vs. “tough reality.” TSLA stock today:
17 November 2025
 ·  ·  ·  ·  · 
Metsera (MTSR) Delists as Pfizer Closes Up to $10 Billion Obesity Drug Deal – All the Key Updates on November 17, 2025

Metsera (MTSR) Delists as Pfizer Closes Up to $10 Billion Obesity Drug Deal – All the Key Updates on November 17, 2025

Pfizer’s acquisition of Metsera, Inc. (formerly NASDAQ: MTSR) is now effectively complete, Metsera’s stock has been delisted, major index providers are removing the name, and antitrust scholars are using the failed Novo Nordisk bid as a case study in “attempted
17 November 2025
 ·  ·  ·  ·  ·  · 
Opendoor (OPEN) News Today: Warrant Dividend, Short Seller Crackdown and Wall Street Caution — November 17, 2025

Opendoor (OPEN) News Today: Warrant Dividend, Short Seller Crackdown and Wall Street Caution — November 17, 2025

Opendoor Technologies (NASDAQ: OPEN) is back in the spotlight as a controversial warrant dividend aimed at short sellers dominates headlines, even as Morgan Stanley reiterates a Hold rating and quants flag huge hedge fund flows. Here’s everything investors need to
17 November 2025
 ·  ·  ·  ·  · 
Ondas Holdings (ONDS) Lands $8.2M Airport Drone Defense Deal and Closes $225M Sentrycs Acquisition on November 17, 2025

Ondas Holdings (ONDS) Lands $8.2M Airport Drone Defense Deal and Closes $225M Sentrycs Acquisition on November 17, 2025

Ondas Holdings Inc. (NASDAQ: ONDS), a provider of autonomous drone systems and private wireless networks, packed several major announcements into Monday, November 17, 2025 – including a new multimillion‑dollar European airport contract, the closing of a $225 million acquisition, and
17 November 2025
 ·  ·  ·  ·  · 
Tonix Pharmaceuticals (TNXP) Jumps as TONMYA, First New Fibromyalgia Drug in 15 Years, Hits U.S. Pharmacies – November 17, 2025

Tonix Pharmaceuticals (TNXP) Jumps as TONMYA, First New Fibromyalgia Drug in 15 Years, Hits U.S. Pharmacies – November 17, 2025

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) moved sharply higher today after the company confirmed that TONMYA™ (cyclobenzaprine HCl sublingual tablets), its newly approved fibromyalgia treatment, is now commercially available by prescription across the United States. GlobeNewswire+1 TONMYA Officially Launches in
17 November 2025
 ·  ·  ·  ·  · 
Galmed Pharmaceuticals (GLMD) Soars on New Cancer Drug Combo Data: What Today’s Breakthrough Means for Investors – November 17, 2025

Galmed Pharmaceuticals (GLMD) Soars on New Cancer Drug Combo Data: What Today’s Breakthrough Means for Investors – November 17, 2025

As of this afternoon, Galmed Pharmaceuticals shares were changing hands around $1.18, up roughly 13% on the day, with more than 41 million shares traded—massively above the stock’s usual daily volume. TipRanks What Galmed Announced Today From its headquarters in
17 November 2025
 ·  ·  ·  ·  · 
Autonomix Medical (AMIX) Stock Doubles on New Pancreatic Cancer Quality‑of‑Life Data – November 17, 2025 Update

Autonomix Medical (AMIX) Stock Doubles on New Pancreatic Cancer Quality‑of‑Life Data – November 17, 2025 Update

All of today’s Autonomix (AMIX) news in one glance – 17 November 2025 As of this afternoon on November 17, 2025, all company‑specific news about Autonomix Medical, Inc. (NASDAQ: AMIX) centers on the same core development: new quality‑of‑life data from
17 November 2025
 ·  ·  ·  ·  · 
1 … 37 38 39 40 41 … 232
Go toTop